Higher	O
Prevalence	O
of	O
Frailty	B:C0424594
Among	O
a	O
Sample	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	O
Middle	O
-	O
aged	O
and	O
Older	O
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	O
Impairment	I:C4041080
and	O
Depressive	O
Symptoms	I:C0086132
.	O

Higher	O
Prevalence	O
of	O
Frailty	O
Among	O
a	O
Sample	O
of	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	O
Middle	O
-	O
aged	O
and	O
Older	O
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	O
Impairment	I:C4041080
and	O
Depressive	O
Symptoms	I:C0086132
.	O

Higher	O
Prevalence	O
of	O
Frailty	O
Among	O
a	O
Sample	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	B:C0439663
Middle	O
-	O
aged	O
and	O
Older	O
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	O
Impairment	I:C4041080
and	O
Depressive	O
Symptoms	I:C0086132
.	O

Higher	O
Prevalence	O
of	O
Frailty	O
Among	O
a	O
Sample	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	O
Middle	O
-	O
aged	O
and	O
Older	B:C0152035
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	O
Impairment	I:C4041080
and	O
Depressive	O
Symptoms	I:C0086132
.	O

Higher	O
Prevalence	O
of	O
Frailty	O
Among	O
a	O
Sample	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	O
Middle	O
-	O
aged	O
and	O
Older	O
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	B:C4041080
Impairment	I:C4041080
and	O
Depressive	O
Symptoms	I:C0086132
.	O

Higher	O
Prevalence	O
of	O
Frailty	O
Among	O
a	O
Sample	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
Infected	O
Middle	O
-	O
aged	O
and	O
Older	O
Chinese	I:C0152035
Adults	O
Is	O
Associated	O
With	O
Neurocognitive	O
Impairment	I:C4041080
and	O
Depressive	B:C0086132
Symptoms	I:C0086132
.	O

We	O
investigated	O
the	O
prevalence	O
and	O
correlates	O
of	O
prefrailty	B:C0243095
/	O
frailty	O
,	O
determined	O
on	O
the	O
basis	O
of	O
the	O
Fried	O
criteria	O
,	O
in	O
Chinese	O
patients	O
with	O
and	O
those	O
without	O
human	O
immunodeficiency	I:C0019693
virus	I:C0019693
(	I:C0019693
HIV	I:C0019693
)	I:C0019693
infection	I:C0019693
.	O

We	O
investigated	O
the	O
prevalence	O
and	O
correlates	O
of	O
prefrailty	O
/	O
frailty	B:C0424594
,	O
determined	O
on	O
the	O
basis	O
of	O
the	O
Fried	O
criteria	O
,	O
in	O
Chinese	O
patients	O
with	O
and	O
those	O
without	O
human	O
immunodeficiency	I:C0019693
virus	I:C0019693
(	I:C0019693
HIV	I:C0019693
)	I:C0019693
infection	I:C0019693
.	O

We	O
investigated	O
the	O
prevalence	O
and	O
correlates	O
of	O
prefrailty	O
/	O
frailty	O
,	O
determined	O
on	O
the	O
basis	O
of	O
the	O
Fried	O
criteria	O
,	O
in	O
Chinese	B:C0152035
patients	O
with	O
and	O
those	O
without	O
human	O
immunodeficiency	I:C0019693
virus	I:C0019693
(	I:C0019693
HIV	I:C0019693
)	I:C0019693
infection	I:C0019693
.	O

We	O
investigated	O
the	O
prevalence	O
and	O
correlates	O
of	O
prefrailty	O
/	O
frailty	O
,	O
determined	O
on	O
the	O
basis	O
of	O
the	O
Fried	O
criteria	O
,	O
in	O
Chinese	O
patients	O
with	O
and	O
those	O
without	O
human	B:C0019693
immunodeficiency	I:C0019693
virus	I:C0019693
(	I:C0019693
HIV	I:C0019693
)	I:C0019693
infection	I:C0019693
.	O

human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
frail	O
or	O
prefrail	O
than	O
controls	O
,	O
and	O
this	O
association	O
remained	O
significant	O
after	O
adjustment	O
for	O
potential	O
confounders	O
(	O
odds	O
ratio	O
,	O
3.79	O
)	O
.	O

human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	B:C0439663
patients	O
were	O
more	O
likely	O
to	O
be	O
frail	O
or	O
prefrail	O
than	O
controls	O
,	O
and	O
this	O
association	O
remained	O
significant	O
after	O
adjustment	O
for	O
potential	O
confounders	O
(	O
odds	O
ratio	O
,	O
3.79	O
)	O
.	O

human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
frail	B:C0871754
or	O
prefrail	O
than	O
controls	O
,	O
and	O
this	O
association	O
remained	O
significant	O
after	O
adjustment	O
for	O
potential	O
confounders	O
(	O
odds	O
ratio	O
,	O
3.79	O
)	O
.	O

human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
frail	O
or	O
prefrail	B:C0243095
than	O
controls	O
,	O
and	O
this	O
association	O
remained	O
significant	O
after	O
adjustment	O
for	O
potential	O
confounders	O
(	O
odds	O
ratio	O
,	O
3.79	O
)	O
.	O

After	O
additional	O
adjustment	O
for	O
neurocognitive	B:C4041080
impairment	I:C4041080
and	O
depressive	O
and	O
insomnia	O
symptoms	I:C0917801
,	O
this	O
association	O
remained	O
significant	O
but	O
attenuated	O
(	O
odds	O
ratio	O
,	O
2.16	O
)	O
.	O

After	O
additional	O
adjustment	O
for	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	B:C0086132
and	O
insomnia	O
symptoms	I:C0917801
,	O
this	O
association	O
remained	O
significant	O
but	O
attenuated	O
(	O
odds	O
ratio	O
,	O
2.16	O
)	O
.	O

After	O
additional	O
adjustment	O
for	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
insomnia	B:C0917801
symptoms	I:C0917801
,	O
this	O
association	O
remained	O
significant	O
but	O
attenuated	O
(	O
odds	O
ratio	O
,	O
2.16	O
)	O
.	O

In	O
the	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
group	O
,	O
these	O
3	O
variables	O
were	O
independently	O
associated	O
with	O
prefrailty	O
/	O
frailty	O
.	O

In	O
the	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	B:C0439663
group	O
,	O
these	O
3	O
variables	O
were	O
independently	O
associated	O
with	O
prefrailty	O
/	O
frailty	O
.	O

In	O
the	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
group	O
,	O
these	O
3	O
variables	O
were	O
independently	O
associated	O
with	O
prefrailty	B:C0243095
/	O
frailty	O
.	O

In	O
the	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
group	O
,	O
these	O
3	O
variables	O
were	O
independently	O
associated	O
with	O
prefrailty	O
/	O
frailty	B:C0424594
.	O

These	O
findings	B:C0243095
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	B:C4041080
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	B:C0086132
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	B:C0917801
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	B:C0243095
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	B:C0424594
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	B:C0439663
patients	O
but	O
require	O
further	O
longitudinal	O
investigation	I:C0023981
.	O

These	O
findings	O
suggest	O
that	O
neurocognitive	O
impairment	I:C4041080
and	O
depressive	O
and	O
/	O
or	O
insomnia	O
symptoms	I:C0917801
may	O
account	O
for	O
a	O
higher	O
prevalence	O
of	O
prefrailty	O
/	O
frailty	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
-	O
infected	O
patients	O
but	O
require	O
further	O
longitudinal	B:C0023981
investigation	I:C0023981
.	O

